| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
16,856 |
15,051 |
$1.15M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,765 |
7,710 |
$345K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,249 |
1,189 |
$157K |
| 88120 |
|
973 |
859 |
$90K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
872 |
854 |
$82K |
| 52000 |
|
457 |
449 |
$79K |
| 51741 |
|
1,236 |
1,210 |
$49K |
| 51798 |
|
2,640 |
2,475 |
$26K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
457 |
439 |
$20K |
| 50590 |
|
12 |
12 |
$9K |
| 99243 |
|
65 |
65 |
$9K |
| 99443 |
|
427 |
393 |
$9K |
| 51728 |
|
25 |
25 |
$7K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
191 |
91 |
$7K |
| 81002 |
|
2,215 |
2,159 |
$7K |
| 99223 |
Prolong inpt eval add15 m |
64 |
53 |
$7K |
| 51797 |
|
25 |
25 |
$6K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
26 |
26 |
$5K |
| 99233 |
Prolong inpt eval add15 m |
144 |
70 |
$5K |
| 45990 |
|
75 |
74 |
$4K |
| 52281 |
|
12 |
12 |
$4K |
| 99215 |
Prolong outpt/office vis |
22 |
21 |
$3K |
| 99205 |
Prolong outpt/office vis |
15 |
15 |
$2K |
| 51784 |
|
25 |
25 |
$2K |
| 88112 |
|
1,037 |
834 |
$2K |
| 95972 |
|
14 |
13 |
$919.93 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
129 |
122 |
$533.76 |
| 88313 |
|
191 |
164 |
$492.00 |
| 99239 |
Hospital discharge day management, more than 30 minutes |
42 |
37 |
$484.94 |
| 36000 |
|
287 |
281 |
$368.85 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
128 |
121 |
$246.37 |
| 76000 |
|
19 |
14 |
$101.30 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
96 |
53 |
$84.74 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
105 |
78 |
$80.32 |
| 74018 |
|
13 |
12 |
$44.07 |
| 87500 |
|
128 |
121 |
$41.07 |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
46 |
25 |
$12.90 |
| 87641 |
|
130 |
122 |
$6.32 |
| 87481 |
|
116 |
109 |
$6.32 |
| 87640 |
|
130 |
122 |
$6.32 |
| 87653 |
|
116 |
109 |
$3.16 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
1,046 |
877 |
$1.00 |
| G9905 |
Patient not screened for tobacco use |
13 |
12 |
$0.00 |
| G0029 |
Tobacco screening not performed or tobacco cessation intervention not provided during the measurement period or in the six months prior to the measurement period |
14 |
13 |
$0.00 |
| 87150 |
|
14 |
13 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
186 |
157 |
$0.00 |
| 1036F |
|
174 |
145 |
$0.00 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
111 |
106 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
125 |
106 |
$0.00 |
| 1123F |
|
13 |
12 |
$0.00 |